ASCO® 2024
Yale Cancer Center
Optimizing Therapy for ER+/PR+/HER2+ Breast Cancer: Ultra-Hypofractionation
FEATURING
Suzanne Evans
- 21 views
- November 7, 2024
Yale Cancer Center
Esophageal Cancer Case Discussion: Workup and Updated Treatment Options
- 105 views
- November 1, 2024
Yale Cancer Center
mCRC Case Discussion: Treatment Options for Unresectable Liver Metastases
- 51 views
- November 1, 2024
- 1
Yale Cancer Center
B-ALL Case Discussion: Management of Relapsed Ph- Disease
- 32 views
- October 29, 2024
Yale Cancer Center
DLBCL Case Discussion: Strategies for 3L Management
FEATURING
Scott Huntington,
Iris Isufi
- 32 views
- October 22, 2024
Yale Cancer Center
Lymphoma Hot Topics in 2024: Focus on DLBCL and cHL
FEATURING
Tarsheen Sethi
- 172 views
- October 21, 2024
- 1
Yale Cancer Center
Myeloid Malignancies: Hot Topics in 2024
FEATURING
Nikolai Podoltsev
- 220 views
- October 21, 2024
Yale Cancer Center
Key NSCLC Trial Updates Including ADAURA and KEYNOTE-671
FEATURING
Sarah Goldberg
- 47 views
- October 21, 2024
- 1
Yale Cancer Center
Key Metastatic NSCLC Trial Updates Including MARIPOSA and FLAURA2
FEATURING
Sarah Goldberg
- 81 views
- October 21, 2024
- 1
Yale Cancer Center
Key GU Cancer Trials of 2024: Treatment Advances in Urothelial and Prostate Cancer
FEATURING
Joseph Kim
- 158 views
- October 21, 2024
Yale Cancer Center
Expert Discussions and Case Insights in Advanced GU Cancers
- 55 views
- October 21, 2024
Yale Cancer Center
Key Trials and Updates in Breast Cancer: Expert Insights
FEATURING
Maryam Lustberg
- 170 views
- October 21, 2024
- 4
Yale Cancer Center
Axillary Management: To Dissect or Not to Dissect
FEATURING
Ellie Proussaloglou
- 30 views
- October 21, 2024
Yale Cancer Center
Case Discussions and Advances in TNBC Management and Treatment Strategies
FEATURING
Andrea Silber,
Adriana Kahn
- 21 views
- October 21, 2024
Yale Cancer Center
Multiple Myeloma: Hot Topics in 2024
FEATURING
Sabrina Browning
- 182 views
- October 21, 2024
- 3
Yale Cancer Center
65 y/o Female With Stage 3 SCLC: Case Review and Latest Trial Insights
- 10 views
- October 21, 2024
Yale Cancer Center
Key Practice-Changing Studies in Neuro-Oncology: Rapid Insights Across Disciplines
FEATURING
Nicholas Blondin
- 43 views
- October 17, 2024
- 1
Yale Cancer Center
Gynecologic Oncology Updates: Expert Perspective on Key Trial Findings
FEATURING
Elena Ratner
- 227 views
- October 17, 2024
- 1
Yale Cancer Center
Expert Insights on Practice Changing and Promising Studies in Melanoma
FEATURING
Harriet Kluger
- 31 views
- October 17, 2024
Yale Cancer Center
Expert Perspectives on Key Trial Insights and Treatment Updates in H&N Cancers
FEATURING
Barbara Burtness
- 65 views
- October 17, 2024
- 1
Yale Cancer Center
AI in Oncology: Challenges and Opportunities
FEATURING
Lucila Ohno-Machado
- 34 views
- October 16, 2024
Yale Cancer Center
Implementing the Best Science in Palliative Care: From Comfort to Cure
FEATURING
Elizabeth Prsic
- 27 views
- October 16, 2024
Yale Cancer Center
The Spine Oncology Program at Yale
FEATURING
Ehud Mendel
- 24 views
- October 16, 2024
Yale Cancer Center
Unraveling the Genetic Tapestry: Advances in Germline Testing
FEATURING
Veda Giri
- 21 views
- October 16, 2024
Yale Cancer Center
New Tools in the Toolbox: PET-Guided Radiotherapy and Proton Therapy
FEATURING
Henry Park
- 14 views
- October 16, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "SCLC Treatment Evolution - Debunking Myths, IO Advances, and Long-Term Strategies"
FEATURING
Anne Chiang
- 409 views
- July 10, 2024
- 2
ecancer
ASCO® 2024 Insights: "Results of Preliminary Safety & Efficacy of Belantamab Mafodotin and Elotuzumab in R/R MM"
FEATURING
Natalia Neparidze
- 73 views
- June 25, 2024
2024 ASCO® Annual Meeting Insights Hub
Development and Validation of RSClinN+ Tool for HR+/HER2- Node-Positive BC
FEATURING
Lajos Pusztai
- 799 views
- June 17, 2024
- 5
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Sorafenib Treatment Duration in Desmoid Tumors"
FEATURING
Philippos Costa
- 57 views
- June 17, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "1L Systemic Therapy Following Adjuvant IO in RCC"
FEATURING
Talal El Zarif
- 230 views
- June 11, 2024